Individualizing Pharmacologic Management of Irritable Bowel Syndrome

    loading  Checking for direct PDF access through Ovid

Abstract

TARGET AUDIENCE

Family physicians and clinicians who wish to gain increased knowledge and competency regarding primary care management of irritable bowel syndrome.

DISCLOSURES

As a continuing medical education provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Primary Care Education Consortium (PCEC) to require any individual in a position to influence educational content to disclose the existence of any financial interest or other personal relationship with the manufacturer(s) of any commercial product(s).

DISCLOSURES

Louis Kuritzky, MD discloses that he is on the advisory board for Amgen Inc, Boehringer Ingelheim GmbH, Daiichi Sankyo, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., sanofi-aventis U.S. LLC, and Takeda Pharmaceuticals U.S.A., Inc. He is on the speakers' bureau for Amgen Inc., Eli Lilly and Company, and Novo Nordisk Inc.

DISCLOSURES

Stephen Brunton, MD, discloses that he serves on the speakers' bureau for AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., and Teva Pharmaceuticals USA, Inc. He also serves as a consultant for Abbott Diabetes Care Inc., Actavis, Inc., AstraZeneca, Becton, Dickinson and Company, BoehringerIngelheim GmbH, Eli Lilly and Company, Exact Sciences Corporation, Janssen Pharmaceuticals, Inc., MEDA Pharmaceuticals Inc., Mylan Inc., Novo Nordisk Inc., and Teva Pharmaceuticals USA, Inc.

DISCLOSURES

Gregory Scott, PharmD, RPh, editorial support, Allan Wilke, MD, CME Reviewer and the additional staff of PCEC disclose that they have no real or apparent conflicts of interest to report.

CONFLICTS OF INTEREST

When individuals in a position to control content have reported financial relationships with one or more commercial interests, PCEC works with them to resolve such conflicts to ensure that the content presented is free of commercial bias. The content of this activity was vetted by the following mechanisms and modified as required to meet this standard:

OFF-LABEL DISCLOSURES

In accordance with ACCME guidelines, the faculty author has been asked to disclose discussion of unlabeled or unapproved uses of drugs or devices during the course of the activity.

SPONSORSHIP

This activity is sponsored by Primary Care Education Consortium.

SUPPORTER

This activity is supported by an educational grant from Forest Laboratories, Inc. and Ironwood Pharmaceuticals.

ACCREDITATION

This activity has been planned and implemented in accordance with the Essential Areas and policies of the ACCME through the sponsorship of Primary Care Education Consortium, which is accredited by the ACCME to provide continuing medical education for physicians.

AMA PRA CATEGORY 1

PCEC designates this activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA CATEGORY 1

Release Date: 10 Dec 2015

AMA PRA CATEGORY 1

Expiration Date: 9 Dec 2016

METHOD OF PARTICIPATION

PHYSICIANS

METHOD OF PARTICIPATION

To receive CME credit, please read the journal article and on completion, go to www.pceconsortium.org/ibs to complete the online evaluation and receive your certificate of completion.

PHYSICIAN ASSISTANTS

AAPA accepts certificates of participation of educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

CASE STUDY.

FB is a 31-year-old female who called the previous day for an appointment with her primary care physician (PCP). The PCP greets FB and says, “You were here 2 weeks ago for a follow-up visit for your asthma. Everything seemed to be okay then. Have you been having difficulties since I saw you?”

CASE STUDY.

FB says “No, my asthma symptoms have been okay. I've wanted to talk with you for some time about something else. I've been having problems going to the bathroom, but there never seems to be time to discuss this when I see you. I just want these problems to go away.”

Related Topics

    loading  Loading Related Articles